Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ionis Pharmaceuticals
Ionis Pharmaceuticals
GSK licenses Ionis' midphase hepatitis B program for $25M
Fierce Biotech
Tue, 08/27/19 - 09:51 am
GSK
Ionis Pharmaceuticals
antisense
hepatitis B
Ionis Pharmaceuticals Looks to Partners to Pay the Bills
Motley Fool
Thu, 08/15/19 - 12:00 am
Ionis Pharmaceuticals
Biogen’s Experimental Drug Shows Promise for Genetic Form of ALS
BioSpace
Wed, 05/15/19 - 11:43 pm
Biogen
tofersen
antisense
Ionis Pharmaceuticals
ALS
'Pathbreaking' Ionis trial offers way forward in Huntington's disease
Biopharma Dive
Mon, 05/6/19 - 07:22 pm
Ionis Pharmaceuticals
Roche
Huntington's disease6
RG6042
Ionis slides after AveXis reports SMA data for Zolgensma
BioCentury
Wed, 04/17/19 - 10:41 pm
Ionis Pharmaceuticals
AveXis
Zolgensma
lcinical trials
spinal muscular atrophy
1 Biotech That Biogen Should Buy ... but Probably Won't
Motley Fool
Thu, 04/4/19 - 11:26 pm
Biogen
Ionis Pharmaceuticals
M&A
Ionis Pharmaceuticals Funds Its Pipeline of More Than 40 Drugs
Motley Fool
Mon, 03/4/19 - 07:33 pm
Ionis Pharmaceuticals
earnings
Novartis aims to pump up cardio business with Ionis deal
Yahoo/Reuters
Mon, 02/25/19 - 09:51 am
Novartis
Ionis Pharmaceuticals
TQJ230
Hunting productivity, drugmakers pitch new 'pillars' of R&D
Biopharma Dive
Sat, 01/12/19 - 11:31 am
R&D
Moderna Therapeutics
Sarepta Therapeutics
Ionis Pharmaceuticals
Biogen opts in for Ionis' ALS candidate, plans pivotal trial
BioCentury
Thu, 12/6/18 - 06:56 pm
BIIB067
Biogen
Ionis Pharmaceuticals
ALS
Ionis, Akcea succeed in heart drug trial, setting up Novartis decision
Biopharma Dive
Tue, 11/13/18 - 10:13 pm
Akcea Therapeutics
Ionis Pharmaceuticals
clinical trials
Novartis
AKCEA-APO(a)-Lrx
AstraZeneca and Ionis target diabetes with antisense approach to regenerating pancreatic cells
Fierce Biotech
Mon, 10/22/18 - 12:17 pm
AstraZeneca
Ionis Pharmaceuticals
type 2 diabetes
antisense
Roche gets option to Ionis' antisense dry AMD candidate
BioCentury
Wed, 10/10/18 - 10:51 pm
Roche
Ionis Pharmaceuticals
IONIS-FB-LRx
antisense
dry age-related macular degeneration
FDA clears rare disease therapy from Akcea, Ionis
Biopharma Dive
Fri, 10/5/18 - 09:38 pm
FDA
Akcea
Ionis Pharmaceuticals
Tegsedi
Onpattro
Alnylam
hATTR amyloidosis
Ionis, Rockefeller team find peripheral blood target for Alzheimer's
BioCentury
Tue, 09/25/18 - 07:47 pm
Ionis Pharmaceuticals
Rockefeller University
Alzheimer's disease
drug development
Why Biogen's Stock Ripped Higher in July
Motley Fool
Mon, 08/13/18 - 09:41 am
Biogen
Eisai
BAN2401
Alzheimer's disease
Spinraza
Ionis Pharmaceuticals
Ionis-backed Dynacure bags €47M to start clinical trials
Fierce Biotech
Fri, 07/6/18 - 10:42 pm
Dynacure
Ionis Pharmaceuticals
antisense
oligonucleotide
CNM muscular disorders
Why PTC Therapeutics Dropped 30.6% Today After Jumping 27.5% Yesterday
Motley Fool
Tue, 06/19/18 - 10:42 pm
PTC Therapeutics
risdiplam
Biogen
Ionis Pharmaceuticals
spinal muscular atrophy
Sarepta Therapeutics
Translarna
Emflaza
FDA Advisory Committee Votes in Favor of Waylivra for Treatment of Familial Chylomicronemia Syndrome
CP Wire
Fri, 05/11/18 - 10:09 am
Akcea Therapeutics
Ionis Pharmaceuticals
FDA
advisory panel
Waylivra
Volanesorsen
FCS
Outlook for Ionis, Akcea drug marred by safety concerns
Biopharma Dive
Wed, 05/9/18 - 09:25 pm
Ionis Pharmaceuticals
Akcea Therapeutics
FDA
advisory panel
Volanesorsen
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »